IV drug safety is our business
SEA Medical Systems, Inc. is a privately held medical device company dedicated to making intravenous (IV) drug delivery safer for patients. We are developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients.
Much attention is given to the celebrity encounters with medical errors, such as the 1,000-fold heparin overdoses that nearly killed Dennis and Kimberly Quaid’s twin infants, but the problem is pervasive. Each year in United States hospitals, adverse drug events (ADEs) cause over 7,000 deaths, 770,000 injuries and $3.5 billion in additional hospital costs. A majority of these events occur with IV medications.
SEA Medical is guided by the following principles: respect for medical professionals and the complexity of their mission, compassion for patients and their needless suffering from avoidable drug errors, and determination to provide a system that improves safety while fitting elegantly with current practice and systems, to accurately detect and report IV drug errors before they harm patients.
